Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (41-50 of 518) with videos related to

Pageof 52
Sort By:
Hematology/Oncology Clinics of North America|October 3, 2007
New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphomaOla Landgren, Neil E Caporaso
British Journal of Haematology|November 21, 2007
Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseasesOla Landgren, Robert A Kyle
JAMA|December 2, 2010
Multiple myeloma precursor diseaseOla Landgren, Adam Justin Waxman
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Sigurdur Y Kristinsson, Ola Landgren
Clinical Chemistry|August 13, 2011
Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammationColin A Hutchison, Ola Landgren
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Biologic frontiers in multiple myeloma: from biomarker identification to clinical practiceOla Landgren, Gareth J Morgan
Seminars in Hematology|January 15, 2011
Development of early treatment strategies for high-risk myeloma precursor disease in the futureOla Landgren, S Vincent Rajkumar
International Journal of Cancer|December 18, 2008
Autoimmunity and lymphomagenesisLynn R Goldin, Ola Landgren
Expert Review of Anticancer Therapy|February 29, 2012
Thromboprophylaxis in multiple myeloma: is the evidence there?Sigurdur Yngvi Kristinsson, Ola Landgren
Leukemia & Lymphoma|August 23, 2011
Associations between non-Hodgkin lymphoma and renal cell carcinomaLindsay M Morton, Ola Landgren
Pageof 52

Showing results (41-50 of 518) with videos related to

Sort By:
Pageof 52
Hematology/Oncology Clinics of North America|October 3, 2007
New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphomaOla Landgren, Neil E Caporaso
British Journal of Haematology|November 21, 2007
Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseasesOla Landgren, Robert A Kyle
JAMA|December 2, 2010
Multiple myeloma precursor diseaseOla Landgren, Adam Justin Waxman
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Sigurdur Y Kristinsson, Ola Landgren
Clinical Chemistry|August 13, 2011
Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammationColin A Hutchison, Ola Landgren
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Biologic frontiers in multiple myeloma: from biomarker identification to clinical practiceOla Landgren, Gareth J Morgan
Seminars in Hematology|January 15, 2011
Development of early treatment strategies for high-risk myeloma precursor disease in the futureOla Landgren, S Vincent Rajkumar
International Journal of Cancer|December 18, 2008
Autoimmunity and lymphomagenesisLynn R Goldin, Ola Landgren
Expert Review of Anticancer Therapy|February 29, 2012
Thromboprophylaxis in multiple myeloma: is the evidence there?Sigurdur Yngvi Kristinsson, Ola Landgren
Leukemia & Lymphoma|August 23, 2011
Associations between non-Hodgkin lymphoma and renal cell carcinomaLindsay M Morton, Ola Landgren
Pageof 52